Europlasma : Nuclear Industry calls on Europlasma once again

Press releaseBordeaux, 7 November 2016

Nuclear Industry calls on Europlasma once again

Europlasma announces today booking an order for the engineering and supply of a plasma heating system for the treatment of intermediate-level radioactive waste on behalf of a world leader in the nuclear industry. This contract, exceeding € 1 million, is part of the French program «programme d'Investissements d'Avenir», in line with the 2016-2018 national plan for the management of radioactive waste (PNGMDR).

The plasma process relies on an innovation: the oxygen torch. The use of pure oxygen as plasma gas (instead of air) optimizes the combustion of the organic fraction of waste and eliminates any formation of nitrogen oxides (NOx) in the process; it also reduces the energy consumption of the torch due to unnecessary heating of the nitrogen in the air. The mineral and metal fractions are vitrified and molten.

This innovative process on an industrial scale, and successfully tested in 2016, allows Europlasma Industries to position itself in a new market segment: the treatment of intermediate-level long-lived waste (IL-LL).

C.E.O. Jean-Eric Petit, declares: «We are proud to offer this innovation. This new contract demonstrates the capacity of Europlasma Industries to expand into new markets with large well- known industrial partners who placed their trust in the know-how and expertise of the Group».

About EUROPLASMA

At the heart of environmental issues, EUROPLASMA designs and develops innovative plasma solutions for renewable energy generation and hazardous waste recovery, as well as related applications for multi-sector companies wishing to reduce their environmental footprint.

EUROPLASMA is listed on Alternext (FR0000044810-ALEUP). For more information: www.europlasam.com

CONTACTS:	Press relations	Investors & Analysts relations
Anne BORDERES	[e-mail]
Tel: + 33 (0) 556 497 000

Important notice

This release contains provisional information and statements based on the best estimates ofthe Management at the date of their publication.This information is by nature subject to risks and uncertainties which are difficult to predict and generally outside the Group's field of action. These risks include the risks listed in the Group's reference document available on its website http://www.europlasma.com. Consequently, the future performance of the Group may differ significantly from the provisional data communicated and the Group can make no commitment to the achievement of these provisional elements.